Boehmer Dirk, Kuczer David, Badakhshi Harun, Stiefel Simone, Kuschke Wolf, Wernecke Klaus Dieter, Budach Volker
Department of Radiation Oncology, University Clinic Charité, Campus Mitte, Berlin, Germany.
Strahlenther Onkol. 2006 May;182(5):277-82. doi: 10.1007/s00066-006-1462-7.
To evaluate rectal dose-volume relations during three-dimensional conformal radiotherapy of patients with prostate cancer by means of different rectal volume contours.
55 patients with prostate cancer underwent three-dimensional conformal external-beam radiotherapy. Rectal dose-volume histograms were calculated for four separately contoured rectal volumes in all patients resulting in four groups. In group 1 the outer rectal wall was contoured two CT slices above and below the planning target volume. The rectal contour of group 2 was drawn from the anal verge up to the sigmoid. Furthermore, the posterior half of the rectum was contoured for both volumes mentioned above (groups 1a and 2a). Statistical analysis was then performed using nonparametric Wilcoxon tests.
The mean target dose was 72.9 Gy (standard deviation [SD] +/- 2.1 Gy). The minimum target dose was 70.2 Gy. Mean rectum dose (+/- SD) over all patients was 50.7 Gy (+/- 4.6 Gy), 45.2 Gy (+/- 5.4 Gy), 43.2 Gy (+/- 4.2 Gy), and 38.7 Gy (+/- 5.5 Gy) for group 1, 2, 1a, and 2a, respectively. The corresponding volumes receiving > or = 70 Gy for groups 1 and 2 were 14.0% (+/- 5.3%) and 11.9% (+/- 4.5%). These differences were statistically significant. Comparison of minimum and mean rectal dose also revealed a statistically significant difference toward higher doses in groups 1 and 1a (p < 0.001). Maximum rectal doses for groups 1 and 2 as well as for groups 1a and 2a revealed no statistically significant difference (p = 1.0).
Data from the literature on normal-tissue complication probability (rectal bleeding) refer to different rectal contours. When applying dose restrictions to the rectum, contouring becomes a significant factor that determines the risk of rectal toxicity. The results of this study show that different ways of rectal contouring significantly influence doses to the rectum. The influence of organ at risk contouring should be considered thoroughly in conformal radiotherapy of prostate cancer patients, especially in dose escalation studies. It is recommended to calculate the doses for absolute rectal volumes and correlate these data with toxicity in order to be able to achieve comparable results among different institutions.
通过不同的直肠体积轮廓评估前列腺癌患者三维适形放疗期间的直肠剂量-体积关系。
55例前列腺癌患者接受三维适形外照射放疗。为所有患者的四个单独勾勒轮廓的直肠体积计算直肠剂量-体积直方图,从而形成四组。在第1组中,直肠外壁在计划靶体积上下各两个CT层面处勾勒轮廓。第2组的直肠轮廓从肛缘绘制至乙状结肠。此外,对上述两个体积(第1a组和第2a组)均勾勒直肠后半部分的轮廓。然后使用非参数Wilcoxon检验进行统计分析。
平均靶剂量为72.9 Gy(标准差[SD]±2.1 Gy)。最小靶剂量为70.2 Gy。所有患者的直肠平均剂量(±SD)在第1组、第2组、第1a组和第2a组中分别为50.7 Gy(±4.6 Gy)、45.2 Gy(±5.4 Gy)、43.2 Gy(±4.2 Gy)和38.7 Gy(±5.5 Gy)。第1组和第2组中接受≥70 Gy剂量的相应体积分别为14.0%(±5.3%)和11.9%(±4.5%)。这些差异具有统计学意义。直肠最小剂量和平均剂量的比较也显示第1组和第1a组中较高剂量存在统计学显著差异(p<0.001)。第1组和第2组以及第1a组和第2a组的直肠最大剂量无统计学显著差异(p = 1.0)。
关于正常组织并发症概率(直肠出血)的文献数据涉及不同的直肠轮廓。在对直肠应用剂量限制时,轮廓勾勒成为决定直肠毒性风险的一个重要因素。本研究结果表明,不同的直肠轮廓勾勒方式会显著影响直肠剂量。在前列腺癌患者的适形放疗中,尤其是在剂量递增研究中,应充分考虑危及器官轮廓勾勒的影响。建议计算绝对直肠体积的剂量并将这些数据与毒性相关联,以便在不同机构之间能够获得可比的结果。